Cite
HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis.
MLA
Gupta, Ravindra K., et al. “HIV-1 Drug Resistance before Initiation or Re-Initiation of First-Line Antiretroviral Therapy in Low-Income and Middle-Income Countries: A Systematic Review and Meta-Regression Analysis.” The Lancet. Infectious Diseases, vol. 18, no. 3, Mar. 2018, pp. 346–55. EBSCOhost, https://doi.org/10.1016/S1473-3099(17)30702-8.
APA
Gupta, R. K., Gregson, J., Parkin, N., Haile-Selassie, H., Tanuri, A., Andrade Forero, L., Kaleebu, P., Watera, C., Aghokeng, A., Mutenda, N., Dzangare, J., Hone, S., Hang, Z. Z., Garcia, J., Garcia, Z., Marchorro, P., Beteta, E., Giron, A., Hamers, R., … Bertagnolio, S. (2018). HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis. The Lancet. Infectious Diseases, 18(3), 346–355. https://doi.org/10.1016/S1473-3099(17)30702-8
Chicago
Gupta, Ravindra K, John Gregson, Neil Parkin, Hiwot Haile-Selassie, Amilcar Tanuri, Liliana Andrade Forero, Pontiano Kaleebu, et al. 2018. “HIV-1 Drug Resistance before Initiation or Re-Initiation of First-Line Antiretroviral Therapy in Low-Income and Middle-Income Countries: A Systematic Review and Meta-Regression Analysis.” The Lancet. Infectious Diseases 18 (3): 346–55. doi:10.1016/S1473-3099(17)30702-8.